CGPA Forms Biosimilars Board

From DCAT Value Chain Insights (VCI)

By Regulatory News posted 04-11-2015 13:11


The Canadian Generic Pharmaceutical Association (CGPA) has established a new CGPA Biosimilars Board and elected Michel Robidoux, president and general manager of Sandoz Canada, as its inaugural chair.

Mr. Robidoux was appointed president and general ganager for Sandoz Canada in 2010 and has more than 25 years of experience in the pharmaceutical, generic, consumer,and medical device industry. He originally joined Sandoz Canada as vice president, sales in 2008. Before joining Sandoz, Mr. Robidoux was vice president at Roche for various business units within the company such as diabetes care, professional diagnostics, molecular diagnostics, and also applied science. Prior to Roche, he worked at Bayer for seven years in sales and marketing.

Source: Canadian Generic Pharmaceutical Association


Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription